{"name":"Amneal Pharmaceuticals, LLC","slug":"amneal-pharmaceuticals-llc","ticker":"","exchange":"","domain":"amnealllc.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Immunology","slug":"immunology","revenue":0,"percentOfTotal":0,"drugCount":2,"colorKey":"oncology","drugs":[{"name":"Diclofenac Sodium Topical Gel, 1%","genericName":"Diclofenac Sodium Topical Gel, 1%","slug":"diclofenac-sodium-topical-gel-1","indication":"Topical relief of pain and inflammation associated with osteoarthritis and other musculoskeletal conditions","status":"marketed"},{"name":"Voltaren Topical Gel, 1%","genericName":"Voltaren Topical Gel, 1%","slug":"voltaren-topical-gel-1","indication":"Relief of pain, inflammation, and stiffness associated with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis","status":"phase_3"}]},{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"immunology","drugs":[{"name":"Vehicle Diclofenac Sodium Topical Gel","genericName":"Vehicle Diclofenac Sodium Topical Gel","slug":"vehicle-diclofenac-sodium-topical-gel","indication":"Topical treatment of actinic keratosis","status":"phase_3"}]}],"pipeline":[{"name":"Diclofenac Sodium Topical Gel, 1%","genericName":"Diclofenac Sodium Topical Gel, 1%","slug":"diclofenac-sodium-topical-gel-1","phase":"marketed","mechanism":"Diclofenac sodium inhibits cyclooxygenase (COX) enzymes to reduce prostaglandin synthesis, thereby decreasing inflammation and pain at the site of topical application.","indications":["Topical relief of pain and inflammation associated with osteoarthritis and other musculoskeletal conditions"],"catalyst":""},{"name":"Vehicle Diclofenac Sodium Topical Gel","genericName":"Vehicle Diclofenac Sodium Topical Gel","slug":"vehicle-diclofenac-sodium-topical-gel","phase":"phase_3","mechanism":"Diclofenac sodium works by inhibiting the enzyme cyclooxygenase (COX), which is involved in the production of prostaglandins, leading to reduced inflammation and pain.","indications":["Topical treatment of actinic keratosis"],"catalyst":""},{"name":"Voltaren Topical Gel, 1%","genericName":"Voltaren Topical Gel, 1%","slug":"voltaren-topical-gel-1","phase":"phase_3","mechanism":"Voltaren Topical Gel, 1% works by reducing inflammation and pain through the inhibition of prostaglandin synthesis.","indications":["Relief of pain, inflammation, and stiffness associated with osteoarthritis, rheumatoid arthritis, and ankylosing spondylitis"],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxONFdaU0Y0NUU4SFRhRmR1blMwdEJZb2xXTTZGdHpXYzZJWWdxQWs3YUw5OG81MTdfODVCWmFRbFRGLUs3Tzl0TV9MRGV4cl9wdEtVZnRLeTlRUmFyb1dLSnJXRk9KN19CY3RuWGluaTJIeVpVUnBMaTFTUXg0RDJvR1NDY1NoeV9MV09OUlpQbGJIWjd2ZTBfanB1Z2tJNTAxZXVDTlBDY3U5alFFVHdGTmxPVzlxXzJGZUM1VWJaQkprb2RK?oc=5","date":"2026-01-28","type":"pipeline","source":"GlobeNewswire","summary":"Amneal Pharmaceuticals Added to S&P SmallCap 600® Index - GlobeNewswire","headline":"Amneal Pharmaceuticals Added to S&P SmallCap 600® Index","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgJBVV95cUxONDN3cFdzZmZiNHNub3JHdFRrQ3ZPQWtCaElvM1V2bkdPTFh4T0JpVXE2VUZDZHk1TE1iUXBjVlEtYmJUYzVkelpZaW9XRnRrdjV6YnpPQkw5SW1XWmRVV2Fobmo2TnhTZndsQjVVVEt0bEl4bFo4NjAzUExJdUt1YkpXSEZYbDJ0QUc5TDJYZzNnSE5HZUVrd3h6SUF3TmdGM3BvV3o4TFdrV2VnekJmcGpTbng1NmNQbWlEdExJajItNHRsSk9uWUFYamluZUFTajBHZ3REQTVYTGdwakJjX3VkNnlkdWhoV0p4SVpWWjNnUXNwS0VPRGR5cmlJa3BobUR3ZC0zb09sbjJBTG1xYkhxUTU0dXhlSFNIemRlRWJZNjlxcGc?oc=5","date":"2025-10-27","type":"pipeline","source":"GlobeNewswire","summary":"Amneal Launches Brekiya® – the First and Only DHE - GlobeNewswire","headline":"Amneal Launches Brekiya® – the First and Only DHE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMisgFBVV95cUxPQWJRMW1MSWxlRXd0OG9uSW1IbEFiV3JPT0wweHJST1FFWFdJdEpoODJGdHgzZm5GQXlIMDJKQ3h6LXU3NEtzajdiaTVtSEx6dEwtTi1FcUg2NzZhVEEyMGIzQ2VSWVRfUmhCUGhTeTlxR2ppcVd4M1pGX2U2cDYxdzRjLThnSkhsVXZ2U1V5MVpIVWt0d2taZ1FRZFVWNXQwNGQ5cTJOWEdDNVlaQ2l0aEN3?oc=5","date":"2025-09-04","type":"regulatory","source":"Fierce Pharma","summary":"Amneal gets FDA warning letter tied to prior recalls of antibacterial products - Fierce Pharma","headline":"Amneal gets FDA warning letter tied to prior recalls of antibacterial products","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiogFBVV95cUxOYUEwTzFoYUdIUWJzaWVWWlpkVEp0TVFFd2xLX0MzOGdGREh1OTFMdlRITkRoakdJS0tURDd3blp1VHFIeFBYdUFEcGVfdHlTN0JBd2NHV3paWmlGUkFCZVpRcVdvSFlLMEtyR2lHVGgyN3c1bUFiVTRUQkdnRWhkVGprT2Rvc0o0RHdCbDR2MGtXTHhhSlBHR1lvUHFHWjQ4MVE?oc=5","date":"2025-08-13","type":"patent","source":"Bloomberg Law News","summary":"Amneal Will End Sale of Calcium-Drip Copies in Patent-Suit Pact - Bloomberg Law News","headline":"Amneal Will End Sale of Calcium-Drip Copies in Patent-Suit Pact","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxORUpUVGtUanJJUGd3Y3QtU1hublk5dnFwZUV5OVI2MG5zdkg0WFJZWEdBM1dVQTVJN2NlUUlCbWI1SE5SQVlaOGhsNXAzeWRQeEhSbjFEai1GVXBCell1eVhpdHJxY0k0ZEVaVW5iUEpzWWtqakVaSm5sYUZWR0pSemMtdVp2dXpXUklqX1NuVEk4UU5Zb0RVV1U0SElqckpU0gFWQVVfeXFMTXdJeTNOckMxWDVZeDlJZ1Q0OEU2M1c4TTZlbHRSek1tR2VhZl84T2Y2MUx6WDhlbEw0akpGMFBIVjdRRURsOEZxQTc4WldEejZUWWhTSWc?oc=5","date":"2025-07-29","type":"pipeline","source":"Law360","summary":"Teva, Amneal End Case Over Listing Inhaler IP In Orange Book - Law360","headline":"Teva, Amneal End Case Over Listing Inhaler IP In Orange Book - Law360","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-06-05","type":"pipeline","source":"The Hindu","summary":"Amneal Pharma recalling three lots of urinary tract infection tablets in U.S. - The Hindu","headline":"Amneal Pharma recalling three lots of urinary tract infection tablets in U.S.","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi5wFBVV95cUxOdFRTT3NmdkNOSGN0NWhCa0VBRlp1M0xOYWZFMjE0OE5yZjNmWU5CVGVQalJ1VnF3VlhiUl9aU0xqZHY3V3B4aWhxbzVQR0NxWDVmQl9PNGpVa2JzQ21IQmV6WGc2b1h4TWlzVW8ydEdMaEI3OUI2ekxRUlIzMHpuM0U1R0lGcUMtMnRGdEVBYlE1M21ScTBiVXpVUlZMY0NvXzJZOWFGT29aUWhOQnpvdmZrQ0xjRC1OclEzbU1lTEZtYVVXMExWUWxGc1p6bnVVWGUzd3l6b01jbVhaRlpLMGFabmRGa00?oc=5","date":"2024-07-31","type":"pipeline","source":"WilmerHale","summary":"The Interplay: Key Decisions at the Intersection of Antitrust and Life Sciences - July 2024 - WilmerHale","headline":"The Interplay: Key Decisions at the Intersection of Antitrust and Life Sciences - July 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipwFBVV95cUxPNTRHQTYxdUh4ajNKa3h1clpDU3NaUDktQnA1aVRVaGxtSkNPaHc3ZnhBRGJxNXV0X2xLRTB5NlNwaUlnc0JzSzZEbnRNXzVXdlBpQTBiclVYNVhwUlMwSDhacnlmTjhPTTVmS0NJZ1pLaDc2a0djOTlVUmg1cmhwczB2ZXpFamRmaDFDWFViZ1pzRDNScVYyS3JabHJaV3VrbUNVbEIxZw?oc=5","date":"2024-06-18","type":"pipeline","source":"Holland & Knight","summary":"Orange Book Concerns Pick Up as Yet Another Issue for Pharmaceutical Manufacturers - Holland & Knight","headline":"Orange Book Concerns Pick Up as Yet Another Issue for Pharmaceutical Manufacturers - Holland & Knight","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitgFBVV95cUxObXB3Si1BSGlwM1Y4RkpBbEZwOENHYnBBUFBNUmdrT3Ztb1NwX2NBVWxEbno5Q3UyTVRybGpHRXRhVWg2ZHp1eVlFMHBscDF5WGF2NnRBZndXQmpaUDZabzQ1N0hHNHAxRl8xeGJ1VnJXY29jNEIyaGlpSVJFS3J3LXQzRW0yeENtM3AzNUNBNjh0SlZzUlFkV0RrekZ4dDlCNE5JQWg0enhVVEZXOTRfbmRfSWlrZw?oc=5","date":"2024-06-10","type":"regulatory","source":"Reuters","summary":"Amneal, US FTC win order removing Teva inhaler patents from FDA list - Reuters","headline":"Amneal, US FTC win order removing Teva inhaler patents from FDA list","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMie0FVX3lxTFBjUzZSSV9VaWNTWk1yaUM5enJCNElDTmF6UVo5QjFoa01tUUlJYlM3eFI1b0V4YWxkRXlIdU91S3JmTHBQQjZXbUI4eG9qT08zeEtpNVU4YkttS3VHRksyT2gxVFVmNWJFeFBLSnQxUzhUM0NScG5uNVdFYw?oc=5","date":"2021-01-13","type":"pipeline","source":"NJBIZ","summary":"Amneal Pharma announces acquisition of Kashiv Specialty - NJBIZ","headline":"Amneal Pharma announces acquisition of Kashiv Specialty","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxQdURwMDFEVDBLZVZ6ZnNsSVc5WkxHU3pteF9ieTFMYUlOSlVxOHNzNjRKcEFva1ZQcTJQYkhlYVlsTXMwTkxZaWJnNVJQdTdEVFMtcW9BcDNQTmt2VUhLcFhweV9EcjhEVktKZEFwbGd2a2JlUlViMFV1b3BoejZKYjR5SEVrZDB0TXV4SEFmU09FYXl5dEc0aUE2SUJpWDFTR1ZNNFN4NGljM0pGQU5ZVV8xNlNXTXVuOC1qWERTNzF0QQ?oc=5","date":"2021-01-13","type":"deal","source":"Pharmaceutical Business review -","summary":"Amneal to acquire substantially all of Kashiv Specialty Pharmaceuticals - Pharmaceutical Business review -","headline":"Amneal to acquire substantially all of Kashiv Specialty Pharmaceuticals - Pharmaceutical Business review -","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxOVGE3XzVsQS1iYTM3dWc3TWZSck9KLXpDUS1ZY3dmeDd3ZjlCWXRpbWlhdTZZRVgwLUpsSFFuT1oyekNKck9FcllBT1EtLXJlTUlKLTlVS09JRlBlZjBsbGF5ek1Jbjd6N3FGNEF5ZUI2dEVwZGxQMUIzU01CblVQY3drbUFrRE5GY1FObkY2TllxUUtJeVdvSDh0cnN1cFE3cjZ0RHA4QXp4ekRzcXNwRWY0bWF2bWc?oc=5","date":"2020-06-12","type":"patent","source":"Ohio Attorney General (.gov)","summary":"Yost Takes Action Against Generic Drug Manufacturers Who Conspired to Inflate, Manipulate Prices - Ohio Attorney General (.gov)","headline":"Yost Takes Action Against Generic Drug Manufacturers Who Conspired to Inflate, Manipulate Prices - Ohio Attorney General","sentiment":"neutral"}],"patents":[],"drugCount":3,"phaseCounts":{"marketed":1,"phase_3":2},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}